IOVANCE BIOTHERAPEUTICS, INC. Research and Development Expense
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Research and Development Expense of $58.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for the quarter ending 2026-06-30 was $58.85M, a 24.48% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for the quarter ending 2026-03-31 was $62.49M, a 17.74% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for the quarter ending 2025-12-31 was $71.20M, a 0.28% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for the quarter ending 2025-09-30 was $75.17M, a 12.14% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for fiscal 2025 was $300.27M, a 8.70% increase from fiscal 2024.
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for fiscal 2024 was $276.23M, a 17.10% decline from fiscal 2023.
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for fiscal 2023 was $333.19M, a 13.03% increase from fiscal 2022.
- IOVANCE BIOTHERAPEUTICS, INC. research and development expense for fiscal 2022 was $294.78M, a 13.80% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 51 month | Research and Development Expense 54 month | Research and Development Expense 57 month | Research and Development Expense 60 month | Research and Development Expense 63 month | Research and Development Expense 66 month | Research and Development Expense 69 month | Research and Development Expense 72 month | Research and Development Expense 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $58.85M 10-Q · filed 2026-08-06 | $121.34M 10-Q · filed 2026-08-06 | $192.54M derived: sum of 3 quarters · filed 2026-08-06 | $267.71M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2026-03-31 | $62.49M 10-Q · filed 2026-05-07 | $133.69M derived: sum of 2 quarters · filed 2026-05-07 | $208.86M derived: sum of 3 quarters · filed 2026-05-07 | $286.79M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-12-31 | $71.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $146.38M derived: sum of 2 quarters · filed 2026-02-24 | $224.31M derived: sum of 3 quarters · filed 2026-08-06 | $300.27M 10-K · filed 2026-02-24 | |||||||||||||
| 2025-09-30 | $75.17M 10-Q · filed 2025-11-06 | $153.10M derived: sum of 2 quarters · filed 2026-08-06 | $229.07M 10-Q · filed 2025-11-06 | $300.07M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||
| 2025-06-30 | $77.93M 10-Q · filed 2026-08-06 | $79.36M 10-Q · filed 2025-08-07 | $153.90M 10-Q · filed 2026-08-06 | $156.24M 10-Q · filed 2025-08-07 | $224.90M derived: sum of 3 quarters · filed 2026-08-06 | $291.94M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-03-31 | $75.97M 10-Q · filed 2026-05-07 | $76.88M 10-Q · filed 2025-05-08 | $146.97M derived: sum of 2 quarters · filed 2026-05-07 | $214.01M derived: sum of 3 quarters · filed 2026-05-07 | $276.09M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||
| 2024-12-31 | $71.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $138.04M derived: sum of 2 quarters · filed 2026-02-24 | $200.13M derived: sum of 3 quarters · filed 2026-02-24 | $276.23M 10-K · filed 2026-02-24 | $282.34M 10-K · filed 2025-02-27 | ||||||||||||
| 2024-09-30 | $67.04M 10-Q · filed 2025-11-06 | $68.25M 10-Q · filed 2024-11-07 | $129.12M derived: sum of 2 quarters · filed 2025-11-06 | $205.22M 10-Q · filed 2025-11-06 | $210.11M 10-Q · filed 2024-11-07 | $285.49M derived: sum of 4 quarters · filed 2026-02-24 | |||||||||||
| 2024-06-30 | $62.08M 10-Q · filed 2025-08-07 | $141.87M 10-Q · filed 2025-08-07 | $218.45M derived: sum of 3 quarters · filed 2026-02-24 | $305.98M derived: sum of 4 quarters · filed 2026-02-24 | |||||||||||||
| 2024-03-31 | $79.78M 10-Q · filed 2025-05-08 | $156.37M derived: sum of 2 quarters · filed 2026-02-24 | $243.90M derived: sum of 3 quarters · filed 2026-02-24 | $330.24M derived: sum of 4 quarters · filed 2026-02-24 | |||||||||||||
| 2023-12-31 | $76.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $164.11M derived: sum of 2 quarters · filed 2026-02-24 | $250.46M derived: sum of 3 quarters · filed 2026-02-24 | $333.19M 10-K · filed 2026-02-24 | $344.08M 10-K · filed 2024-02-28 | ||||||||||||
| 2023-09-30 | $87.53M 10-Q · filed 2024-11-07 | $173.87M derived: sum of 2 quarters · filed 2024-11-07 | $256.61M 10-Q · filed 2024-11-07 | $337.18M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2023-06-30 | $86.35M 10-Q · filed 2024-08-08 | $169.08M 10-Q · filed 2024-08-08 | $249.65M derived: sum of 3 quarters · filed 2025-02-27 | $322.16M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2023-03-31 | $82.73M 10-Q · filed 2024-05-09 | $163.31M derived: sum of 2 quarters · filed 2025-02-27 | $235.81M derived: sum of 3 quarters · filed 2025-02-27 | $309.21M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||
| 2022-12-31 | $80.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $153.07M derived: sum of 2 quarters · filed 2025-02-27 | $226.48M derived: sum of 3 quarters · filed 2025-02-27 | $294.78M 10-K · filed 2025-02-27 | |||||||||||||
| 2022-09-30 | $72.50M 10-Q · filed 2023-11-07 | $145.91M derived: sum of 2 quarters · filed 2023-11-07 | $214.21M 10-Q · filed 2023-11-07 | $289.82M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||
| 2022-06-30 | $73.41M 10-Q · filed 2023-08-08 | $141.71M 10-Q · filed 2023-08-08 | $217.32M derived: sum of 3 quarters · filed 2024-02-28 | $282.68M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||
| 2022-03-31 | $68.30M 10-Q · filed 2023-05-10 | $143.92M derived: sum of 2 quarters · filed 2024-02-28 | $209.27M derived: sum of 3 quarters · filed 2024-02-28 | $271.39M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||
| 2021-12-31 | $75.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $140.97M derived: sum of 2 quarters · filed 2024-02-28 | $203.09M derived: sum of 3 quarters · filed 2024-02-28 | $259.04M 10-K · filed 2024-02-28 | |||||||||||||
| 2021-09-30 | $65.36M 10-Q · filed 2022-11-03 | $127.47M derived: sum of 2 quarters · filed 2022-11-03 | $183.42M 10-Q · filed 2022-11-03 | $235.87M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||
| 2021-06-30 | $62.12M 10-Q · filed 2022-08-04 | $118.07M 10-Q · filed 2022-08-04 | $170.52M derived: sum of 3 quarters · filed 2023-02-28 | $213.57M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||
| 2021-03-31 | $55.95M 10-Q · filed 2022-05-05 | $108.40M derived: sum of 2 quarters · filed 2023-02-28 | $151.45M derived: sum of 3 quarters · filed 2023-02-28 | $200.72M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||
| 2020-12-31 | $52.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $95.50M derived: sum of 2 quarters · filed 2023-02-28 | $144.78M derived: sum of 3 quarters · filed 2023-02-28 | $201.73M 10-K · filed 2023-02-28 | |||||||||||||
| 2020-09-30 | $43.05M 10-Q · filed 2021-11-04 | $92.32M derived: sum of 2 quarters · filed 2021-11-04 | $149.28M 10-Q · filed 2021-11-04 | $203.51M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||
| 2020-06-30 | $49.27M 10-Q · filed 2021-08-05 | $106.23M 10-Q · filed 2021-08-05 | $160.46M derived: sum of 3 quarters · filed 2022-02-24 | $202.05M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||
| 2020-03-31 | $56.95M 10-Q · filed 2021-05-06 | $111.19M derived: sum of 2 quarters · filed 2022-02-24 | $152.77M derived: sum of 3 quarters · filed 2022-02-24 | $192.07M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||
| 2019-12-31 | $54.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $95.82M derived: sum of 2 quarters · filed 2022-02-24 | $135.12M derived: sum of 3 quarters · filed 2022-02-24 | $166.02M 10-K · filed 2022-02-24 | |||||||||||||
| 2019-09-30 | $41.58M 10-Q · filed 2020-11-05 | $80.88M derived: sum of 2 quarters · filed 2020-11-05 | $111.78M 10-Q · filed 2020-11-05 | $139.20M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||
| 2019-06-30 | $39.30M 10-Q · filed 2020-08-06 | $70.20M 10-Q · filed 2020-08-06 | $97.62M derived: sum of 3 quarters · filed 2021-02-25 | $125.57M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||
| 2019-03-31 | $30.91M 10-Q · filed 2020-05-05 | $58.32M derived: sum of 2 quarters · filed 2021-02-25 | $86.27M derived: sum of 3 quarters · filed 2021-02-25 | $110.82M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||
| 2018-12-31 | $27.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $55.37M derived: sum of 2 quarters · filed 2021-02-25 | $79.92M derived: sum of 3 quarters · filed 2021-02-25 | $99.83M 10-K · filed 2021-02-25 | |||||||||||||
| 2018-09-30 | $27.95M 10-Q · filed 2019-11-04 | $52.50M derived: sum of 2 quarters · filed 2019-11-04 | $72.41M 10-Q · filed 2019-11-04 | $93.11M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||
| 2018-06-30 | $24.55M 10-Q · filed 2019-08-01 | $44.46M 10-Q · filed 2019-08-01 | $65.16M derived: sum of 3 quarters · filed 2020-02-25 | $81.84M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||
| 2018-03-31 | $19.91M 10-Q · filed 2019-05-07 | $40.61M derived: sum of 2 quarters · filed 2020-02-25 | $57.29M derived: sum of 3 quarters · filed 2020-02-25 | $75.93M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||
| 2017-12-31 | $20.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $37.38M derived: sum of 2 quarters · filed 2020-02-25 | $56.02M derived: sum of 3 quarters · filed 2020-02-25 | $71.61M 10-K · filed 2020-02-25 | |||||||||||||
| 2017-09-30 | $16.68M 10-Q · filed 2018-11-06 | $17.75M 10-Q · filed 2017-11-02 | $35.33M derived: sum of 2 quarters · filed 2018-11-06 | $50.92M 10-Q · filed 2018-11-06 | $54.03M 10-Q · filed 2017-11-02 | $60.66M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||
| 2017-06-30 | $18.65M 10-Q · filed 2018-08-07 | $19.65M 10-Q · filed 2017-08-03 | $34.24M 10-Q · filed 2018-08-07 | $36.28M 10-Q · filed 2017-08-03 | $43.98M derived: sum of 3 quarters · filed 2019-02-28 | $52.46M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||
| 2017-03-31 | $15.59M 10-Q · filed 2018-05-10 | $16.62M 10-Q · filed 2017-05-03 | $25.33M derived: sum of 2 quarters · filed 2019-02-28 | $33.81M derived: sum of 3 quarters · filed 2019-02-28 | $38.28M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||
| 2016-12-31 | $9.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $18.22M derived: sum of 2 quarters · filed 2019-02-28 | $22.68M derived: sum of 3 quarters · filed 2019-02-28 | $26.94M 10-K · filed 2019-02-28 | $28.04M 10-K · filed 2017-03-09 | ||||||||||||
| 2016-09-30 | $8.48M 10-Q · filed 2017-11-02 | $12.94M derived: sum of 2 quarters · filed 2017-11-02 | $17.20M 10-Q · filed 2017-11-02 | $21.19M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||
| 2016-06-30 | $4.46M 10-Q · filed 2017-08-03 | $8.65M 10-Q · filed 2017-08-03 | $12.71M derived: sum of 3 quarters · filed 2018-03-12 | $17.67M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||
| 2016-03-31 | $4.19M 10-Q · filed 2017-05-03 | $8.25M derived: sum of 2 quarters · filed 2018-03-12 | $13.21M derived: sum of 3 quarters · filed 2018-03-12 | $17.26M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||
| 2015-12-31 | $4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $9.02M derived: sum of 2 quarters · filed 2018-03-12 | $13.07M derived: sum of 3 quarters · filed 2018-03-12 | $15.47M 10-K · filed 2018-03-12 | |||||||||||||
| 2015-09-30 | $4.96M 10-Q · filed 2016-11-04 | $4.98M 10-Q · filed 2015-11-06 | $9.02M derived: sum of 2 quarters · filed 2016-11-04 | $11.41M 10-Q · filed 2016-11-04 | $12.15M 10-Q · filed 2015-11-06 | $14.24M derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||
| 2015-06-30 | $4.05M 10-Q · filed 2016-08-09 | $4.06M 10-Q · filed 2015-08-10 | $6.84M 10-Q · filed 2016-08-09 | $6.84M 10-Q · filed 2015-08-10 | $9.28M derived: sum of 3 quarters · filed 2017-03-09 | $9.64M derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||
| 2015-03-31 | $2.40M 10-Q · filed 2016-05-09 | $2.01M 10-Q · filed 2015-05-11 | $5.23M derived: sum of 2 quarters · filed 2017-03-09 | $5.58M derived: sum of 3 quarters · filed 2017-03-09 | $6.08M derived: sum of 4 quarters · filed 2017-03-09 | ||||||||||||
| 2014-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $3.19M derived: sum of 2 quarters · filed 2017-03-09 | $3.68M derived: sum of 3 quarters · filed 2017-03-09 | $3.85M 10-K · filed 2017-03-09 | $2.70M 10-K · filed 2015-03-16 | ||||||||||||
| 2014-09-30 | $354.00K 10-Q · filed 2015-11-06 | $353.88K 10-Q · filed 2014-11-13 | $847.99K derived: sum of 2 quarters · filed 2015-11-06 | $1.02M 10-Q · filed 2015-11-06 | $1.02M 10-Q · filed 2014-11-13 | $2.53M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||||
| 2014-06-30 | $493.99K 10-Q · filed 2015-08-10 | $361.23K 10-Q · filed 2014-08-08 | $1.22M 10-Q · filed 2015-08-10 | $663.89K 10-Q · filed 2014-08-08 | $2.18M derived: sum of 3 quarters · filed 2016-03-11 | $2.43M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||||
| 2014-03-31 | $302.66K 10-Q · filed 2015-05-11 | $1.69M derived: sum of 2 quarters · filed 2016-03-11 | $1.94M derived: sum of 3 quarters · filed 2016-03-11 | $2.19M derived: sum of 4 quarters · filed 2016-03-11 | $5.22M 10-Q · filed 2014-05-14 | ||||||||||||
| 2013-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $1.63M derived: sum of 2 quarters · filed 2016-03-11 | $1.88M derived: sum of 3 quarters · filed 2016-03-11 | $2.15M 10-K · filed 2016-03-11 | $1.33M 10-K · filed 2014-03-28 | $4.91M 10-K · filed 2014-03-28 | |||||||||||
| 2013-09-30 | $250.00K 10-Q · filed 2014-11-13 | $500.00K derived: sum of 2 quarters · filed 2014-11-13 | $770.00K 10-Q · filed 2014-11-13 | $1.02M derived: sum of 4 quarters · filed 2014-11-13 | $4.35M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | $250.00K 10-Q · filed 2014-08-08 | $520.00K 10-Q · filed 2014-08-08 | $770.00K derived: sum of 3 quarters · filed 2014-08-08 | $1.02M derived: sum of 4 quarters · filed 2014-08-08 | $4.10M 10-Q · filed 2013-10-23 | ||||||||||||
| 2013-03-31 | $270.00K 10-Q · filed 2014-05-14 | $520.00K derived: sum of 2 quarters · filed 2014-05-14 | $770.00K derived: sum of 3 quarters · filed 2014-05-14 | $1.04M derived: sum of 4 quarters · filed 2014-05-14 | $3.85M 10-Q · filed 2013-10-23 | ||||||||||||
| 2012-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $500.00K derived: sum of 2 quarters · filed 2014-03-28 | $770.00K derived: sum of 3 quarters · filed 2014-03-28 | $1.66M 10-K · filed 2014-03-28 | $3.58M 10-K · filed 2013-09-23 | ||||||||||||
| 2012-09-30 | $250.00K 10-Q · filed 2013-11-14 | $520.00K derived: sum of 2 quarters · filed 2013-11-14 | $1.41M 10-Q · filed 2013-11-14 | $3.16M derived: sum of 4 quarters · filed 2013-11-14 | $3.33M 10-Q · filed 2013-01-25 | ||||||||||||
| 2012-06-30 | $270.00K 10-Q · filed 2013-10-23 | $1.16M 10-Q · filed 2013-10-23 | $2.91M derived: sum of 3 quarters · filed 2013-10-23 | $2.91M derived: sum of 4 quarters · filed 2013-10-23 | $3.08M 10-Q/A · filed 2012-09-10 | ||||||||||||
| 2012-03-31 | $886.00K 10-Q · filed 2013-10-23 | $2.64M derived: sum of 2 quarters · filed 2013-10-23 | $2.64M derived: sum of 3 quarters · filed 2013-10-23 | $2.81M 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | $1.76M derived: sum of 2 quarters · filed 2013-09-23 | $1.76M 10-K · filed 2013-09-23 | $1.93M 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2013-01-25 | $0.00 10-Q · filed 2013-01-25 | |||||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $171.48K 10-K · filed 2012-03-30 | ||||||||||||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |